Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Manitoba

$37,011.00

Role of PPARS and LXRs in mechanisms explaining the effects of different dietary components on lipid metabolism

EF 2009-10

Résumé
In recent years, dietary lipids have been considered more than just sources of energy. It is now understood that fatty acids and cholesterol may affect gene expression in ways that involve specific nuclear systems termed peroxisome proliferator-activated receptors (PPAR) and liver X receptors (LXR). These receptors have been shown to mediate effects of both fatty acids and sterols on lipid metabolism in ways that may affect and individual risk for heart disease and obesity. PPARs have been shown to regulate lipid metabolism including fatty acid oxidation, fat cell development, lipoprotein metabolism and glucose homeostasis. LXRs have been shown to regulate cholesterol absorption, efflux of cholesterol from peripheral cells and metabolism of VLDL. However, possible linkages between PPARs and LXRs, as well as their role in regulating the effect of type of dietary components on lipid metabolism, have yet to be explored. In addition, fatty acids and sterols found in plants (phytosterols) are thought to affect the production of important appetite regulators leptin and ghrelin. The global objective of the present study is to use both in vitro and in vivo models to investigate links between PPARs and LXRs and their role in regulating the effect of different dietary components on lipid metabolism and appetite regulation. To achieve the stated objectives, the in vitro experiments will examine the response to different dietary agents of both known and unknown genes of lipid metabolism using modern genetic profiling analyses. In the second part of the program the role of qualitative fat and sterol consumption will be examined in the regulation of lipid pathways in a mouse model using genes found to be differentially expressed in the initial series of cell-based experiments. It is anticipated that results from the proposed series of experiments should enable innovative nutraceutical/pharmaceutical approaches to improving heart disease and obesity prevalence of Canadians.objective of the present study is to use both in vitro and in vivo models to investigate links between PPARs and LXRs and their role in regulating the effect of different dietary components on lipid metabolism.
Programme
Discovery Grants Program - Individual
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
180398-2007
Name nom
Jones, Peter
Department département
Richardson Centre for Functional Foods and Nutraceuticals
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2007
Award amount
37011
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1011
Committee name en
Integrative Animal Biology
Committee name fr
Biologie Animale Intégrative
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5405
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Lipids
Research subject fr
Lipides
Partie
3
Nb partie
5
Application title
Role of PPARS and LXRs in mechanisms explaining the effects of different dietary components on lipid metabolism
Keyword
NA
Application summary
In recent years, dietary lipids have been considered more than just sources of energy. It is now understood that fatty acids and cholesterol may affect gene expression in ways that involve specific nuclear systems termed peroxisome proliferator-activated receptors (PPAR) and liver X receptors (LXR). These receptors have been shown to mediate effects of both fatty acids and sterols on lipid metabolism in ways that may affect and individual risk for heart disease and obesity. PPARs have been shown to regulate lipid metabolism including fatty acid oxidation, fat cell development, lipoprotein metabolism and glucose homeostasis. LXRs have been shown to regulate cholesterol absorption, efflux of cholesterol from peripheral cells and metabolism of VLDL. However, possible linkages between PPARs and LXRs, as well as their role in regulating the effect of type of dietary components on lipid metabolism, have yet to be explored. In addition, fatty acids and sterols found in plants (phytosterols) are thought to affect the production of important appetite regulators leptin and ghrelin. The global objective of the present study is to use both in vitro and in vivo models to investigate links between PPARs and LXRs and their role in regulating the effect of different dietary components on lipid metabolism and appetite regulation. To achieve the stated objectives, the in vitro experiments will examine the response to different dietary agents of both known and unknown genes of lipid metabolism using modern genetic profiling analyses. In the second part of the program the role of qualitative fat and sterol consumption will be examined in the regulation of lipid pathways in a mouse model using genes found to be differentially expressed in the initial series of cell-based experiments. It is anticipated that results from the proposed series of experiments should enable innovative nutraceutical/pharmaceutical approaches to improving heart disease and obesity prevalence of Canadians.objective of the present study is to use both in vitro and in vivo models to investigate links between PPARs and LXRs and their role in regulating the effect of different dietary components on lipid metabolism.